KRAS, KRAS proto-oncogene, GTPase, 3845

N. diseases: 1213; N. variants: 54
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0940937
Disease: precancerous lesions
precancerous lesions
0.040 GeneticVariation phenotype BEFREE Most pancreatic ductal adenocarcinoma (PDAC) develops from pancreatic epithelial cells bearing activating mutant KRAS genes through precancerous lesions, i.e. acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia (PanIN). 30705405 2019
CUI: C0940937
Disease: precancerous lesions
precancerous lesions
0.040 GeneticVariation phenotype BEFREE Pancreatic juice from PDAC patients is rich in KRAS mutations often not seen in the primary tumor and possibly reflecting precancerous lesions in other regions of the pancreas. 30611220 2019
CUI: C0940937
Disease: precancerous lesions
precancerous lesions
0.040 AlteredExpression phenotype BEFREE Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. 25361845 2015
CUI: C0940937
Disease: precancerous lesions
precancerous lesions
0.040 GeneticVariation phenotype BEFREE DNA was isolated from paired normal and tumoral tissues in 78 tubular adenomas (TAs), 34 serrated polyps (SPs), and 100 CRCs. mtMSI, nucleus microsatellite instability (nMSI), KRAS mutation, and BRAF mutation were investigated in these tumors and their statistical analysis was performed. mtMSI was found in 30% of CRCs and 21.4% of precancerous lesions. 25734426 2015